Non-invasive cardiac and pulmonary pressure monitoring - unique biomarkers for disease monitoring and management

Acorai is developing a first-in-class non-invasive hemodynamic monitoring device that estimates right (RAP)- and left-sided (PCWP) cardiac pressures.

Non-invaisve and scalable access to these pressures can enable enabling personalized therapy at the point of care, for multitude of disease areas.

The team is looking for consortium partners to develop unique and impactful clinical insights for clinical and commercial implementation.